Danon Disease: Entire LAMP2 Gene Deletion with Unusual Clinical Presentation-Case Report and Review of the Literature

Genes (Basel). 2023 Jul 27;14(8):1539. doi: 10.3390/genes14081539.

Abstract

Danon disease is a rare x-linked dominant multisystemic disorder with a clinical triad of severe cardiomyopathy, skeletal myopathy, and intellectual disability. It is caused by defects in the lysosome-associated membrane protein-2 (LAMP2) gene. Numerous different mutations in the LAMP2 protein have been described. Danon disease is typically lethal by the mid-twenties in male patients due to cardiomyopathy and heart failure. Female patients usually present with milder and variable symptoms. This report describes a 42-year-old father and his 3-year-old daughter presenting with mild manifestations of the disease. The father has normal intellectual development and normal physical activity. At the age of 13, he was diagnosed with mild ventricular pre-excitation known as Wolf-Parkinson-White syndrome (WPWs), very mild and mostly asymptomatic cardiomyopathy and left ventricular hypertrophy, and at about the age of 25 presented with visual impairment due to cone-rod dystrophy. His daughter showed normal development and very mild asymptomatic electrocardiographic WPWs abnormalities with left mild ventricular hypertrophy. Genetic testing revealed an Xq24 microdeletion encompassing the entire LAMP2 gene. Relevant literature was reviewed as a reference for the etiology, diagnosis, treatment and case management.

Keywords: Danon disease; LAMP2-gene; genotype-phenotype correlation; microdeletion; penetrance; whole-exome-sequence.

Publication types

  • Review
  • Case Reports
  • Research Support, Non-U.S. Gov't

MeSH terms

  • Cone-Rod Dystrophies*
  • Female
  • Gene Deletion
  • Genes, Regulator
  • Glycogen Storage Disease Type IIb* / diagnosis
  • Glycogen Storage Disease Type IIb* / genetics
  • Heart Failure*
  • Humans
  • Lysosomal-Associated Membrane Protein 2 / genetics
  • Male

Substances

  • LAMP2 protein, human
  • Lysosomal-Associated Membrane Protein 2

Grants and funding

The project was funded by Ginatuna, a non-profit organization in Sakhnin City, Israel.